Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Melanoma D008545 69 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Psoriasis D011565 47 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Pyne S and Pyne NJ Sphingosine 1-phosphate signalling in mammalian cells. 2000 Biochem. J. pmid:10880336
Pyne S and Pyne N Sphingosine 1-phosphate signalling via the endothelial differentiation gene family of G-protein-coupled receptors. 2000 Pharmacol. Ther. pmid:11150592
Conway A et al. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells. 2000 Cell. Signal. pmid:11152959
Brindley DN et al. Analysis of ceramide 1-phosphate and sphingosine-1-phosphate phosphatase activities. 2000 Meth. Enzymol. pmid:10563330
Rümenapp U et al. Sphingolipid receptor signaling and function in human bladder carcinoma cells: inhibition of LPA- but enhancement of thrombin-stimulated cell motility. 2000 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10651140
Lee OH et al. Sphingosine 1-phosphate stimulates tyrosine phosphorylation of focal adhesion kinase and chemotactic motility of endothelial cells via the G(i) protein-linked phospholipase C pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10652210
Sato K et al. Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells. 2000 Brain Res. Mol. Brain Res. pmid:11146117
Hla T et al. Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818438
Spiegel S Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818441
Ancellin N and Hla T Switching intracellular signaling pathways to study sphingosine 1-phosphate receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818459
Yamamura S et al. Sphingosine-1-phosphate inhibits haptotactic motility by overproduction of focal adhesion sites in B16 melanoma cells through EDG-induced activation of Rho. 2000 Ann. N. Y. Acad. Sci. pmid:10818470
Gallois C et al. Endothelin-1 stimulates sphingosine kinase in human hepatic stellate cells. A novel role for sphingosine-1-P as a mediator of growth inhibition. 2000 Ann. N. Y. Acad. Sci. pmid:10818472
Gennero I et al. Effect of sphingosine-1-phosphate and analogues of lysophosphatidic acid on mesangial cell proliferation. 2000 Ann. N. Y. Acad. Sci. pmid:10818478
Alessenko AV The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. 2000 Membr Cell Biol pmid:10779176
Miura Y et al. Rho-mediated phosphorylation of focal adhesion kinase and myosin light chain in human endothelial cells stimulated with sphingosine 1-phosphate, a bioactive lysophospholipid released from activated platelets. 2000 J. Biochem. pmid:10788802
Im DS et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. 2000 J. Biol. Chem. pmid:10799507
Goetzl EJ et al. Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. 2000 J. Immunol. pmid:10799850
Nava VE et al. Functional characterization of human sphingosine kinase-1. 2000 FEBS Lett. pmid:10802064
Spiegel S and Milstien S Functions of a new family of sphingosine-1-phosphate receptors. 2000 Biochim. Biophys. Acta pmid:10760461
Panetti TS et al. Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration. 2000 Arterioscler. Thromb. Vasc. Biol. pmid:10764666
Boguslawski G et al. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. 2000 Biochem. Biophys. Res. Commun. pmid:10833459
Kimura T et al. Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. 2000 Biochem. J. pmid:10794715
Meacci E et al. Permissive role of protein kinase C alpha but not protein kinase C delta in sphingosine 1-phosphate-induced Rho A activation in C2C12 myoblasts. 2000 FEBS Lett. pmid:11018530
Okamoto H et al. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. 2000 Mol. Cell. Biol. pmid:11094076
Murata N et al. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. 2000 Biochem. J. pmid:11104690
Shimizu H et al. Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. 2000 Endocr. J. pmid:11036869
MacLennan AJ et al. Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth. 2000 Dev. Neurosci. pmid:10965150
Nakajima N et al. Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate. 2000 Eur. J. Biochem. pmid:10971577
Parrill AL et al. Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate. 2000 J. Biol. Chem. pmid:10982820
Davaille J et al. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. 2000 J. Biol. Chem. pmid:10942778
Pitson SM et al. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. 2000 J. Biol. Chem. pmid:10944534
Nugent D and Xu Y Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation. 2000 Platelets pmid:10938902
Young KW et al. Effect of dimethylsphingosine on muscarinic M(3) receptor signalling in SH-SY5Y cells. 2000 Eur. J. Pharmacol. pmid:10940357
Bischoff A et al. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. 2000 Br. J. Pharmacol. pmid:10952677
Bischoff A et al. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. 2000 Br. J. Pharmacol. pmid:10952678
Alemany R et al. Stimulation of sphingosine-1-phosphate formation by the P2Y(2) receptor in HL-60 cells: Ca(2+) requirement and implication in receptor-mediated Ca(2+) mobilization, but not MAP kinase activation. 2000 Mol. Pharmacol. pmid:10953041
Young KW et al. Lysophosphatidic acid-induced Ca2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptors. 2000 J. Biol. Chem. pmid:10954727
Peyruchaud O and Mosher DF Differential stimulation of signaling pathways initiated by Edg-2 in response to lysophosphatidic acid or sphingosine-1-phosphate. 2000 Cell. Mol. Life Sci. pmid:10961347
Casper RF and Jurisicova A Protecting the female germ line from cancer therapy. 2000 Nat. Med. pmid:11017136
Morita Y et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. 2000 Nat. Med. pmid:11017141
Yanai N et al. Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers. 2000 Blood pmid:10891442
Prieschl EE and Baumruker T Beyond a structural component: sphingolipids in immunology. 2000 Arch. Immunol. Ther. Exp. (Warsz.) pmid:10912620
Ikeda H et al. Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10915638
Yamazaki Y et al. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10679247
Lee H et al. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. 2000 Am. J. Physiol., Cell Physiol. pmid:10712250
Motohashi K et al. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. 2000 FEBS Lett. pmid:10692584
Sugiyama A et al. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. 2000 Cardiovasc. Res. pmid:10727660
Kozawa O et al. Sphingosine 1-phosphate amplifies phosphoinositide hydrolysis stimulated by prostaglandin f2 alpha in osteoblasts: involvement of p38MAP kinase. 2000 Prostaglandins Leukot. Essent. Fatty Acids pmid:10913228
Okamoto H et al. Sphingosine 1-phosphate stimulates G(i)- and Rho-mediated vascular endothelial cell spreading and migration. 2000 Thromb. Res. pmid:10942792
Takeshita A et al. Selective stimulation by ceramide of the expression of the alpha isoform of retinoic acid and retinoid X receptors in osteoblastic cells. A role of sphingosine 1-phosphate-mediated AP-1 in the ligand-dependent transcriptional activity of these receptors. 2000 J. Biol. Chem. pmid:10915783